$1.79
0.0%
Downside
Day's Volatility :7.73%
Upside
7.73%
82.04%
Downside
52 Weeks Volatility :97.08%
Upside
83.73%
Period | Tff Pharmaceuticals Inc | Sector (Health Care) | Index (Russel 2000) |
---|---|---|---|
3 Months | 1.7% | 5.1% | 0.0% |
6 Months | -78.27% | 4.9% | 0.0% |
1 Year | -80.82% | 16.6% | 0.0% |
3 Years | -99.16% | 13.2% | -22.3% |
Market Capitalization | 6.8M |
Book Value | $1.81 |
Earnings Per Share (EPS) | -6.88 |
Wall Street Target Price | 30.0 |
Profit Margin | 0.0% |
Operating Margin TTM | -609.42% |
Return On Assets TTM | -105.91% |
Return On Equity TTM | -213.51% |
Revenue TTM | 1.2M |
Revenue Per Share TTM | 0.47 |
Quarterly Revenue Growth YOY | 95.1% |
Gross Profit TTM | -21.2M |
EBITDA | -19.0M |
Diluted Eps TTM | -6.88 |
Quarterly Earnings Growth YOY | 0.0 |
EPS Estimate Current Year | -4.28 |
EPS Estimate Next Year | -3.77 |
EPS Estimate Current Quarter | -1.7 |
EPS Estimate Next Quarter | -1.35 |
What analysts predicted
Upside of 1575.98%
Sell
Neutral
Buy
Tff Pharmaceuticals Inc is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.
Company Name | 1 Month | 6 Month | 1 Year | 3 Years | 5 Years |
---|---|---|---|---|---|
![]() Tff Pharmaceuticals Inc | 29.71% | -78.27% | -80.82% | -99.16% | -98.59% |
![]() Regeneron Pharmaceuticals, Inc. | 5.97% | 16.25% | 37.11% | 69.18% | 305.56% |
![]() Novo Nordisk A/s | 9.99% | -3.52% | 34.24% | 158.74% | 417.73% |
![]() Alnylam Pharmaceuticals, Inc. | -5.15% | 64.67% | 22.72% | 31.08% | 198.44% |
![]() Vertex Pharmaceuticals Incorporated | 0.45% | 14.0% | 36.06% | 143.5% | 167.72% |
Company Name | P/E Ratio | P/B Ratio | PEG Ratio | EPS | ROE | ROA | Div Yield | BVPS |
---|---|---|---|---|---|---|---|---|
![]() Tff Pharmaceuticals Inc | NA | NA | NA | -4.28 | -2.14 | -1.06 | NA | 1.81 |
![]() Regeneron Pharmaceuticals, Inc. | 29.93 | 29.93 | 1.54 | 45.05 | 0.17 | 0.08 | NA | 261.41 |
![]() Novo Nordisk A/s | 44.01 | 44.01 | 1.98 | 3.44 | 0.89 | 0.23 | 0.01 | 25.24 |
![]() Alnylam Pharmaceuticals, Inc. | NA | NA | -0.49 | -2.55 | -15.01 | 0.02 | NA | -0.02 |
![]() Vertex Pharmaceuticals Incorporated | 32.84 | NA | 0.57 | 0.32 | -0.03 | 0.13 | NA | 57.26 |
Company Name | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin |
---|---|---|---|---|---|
![]() Tff Pharmaceuticals Inc | Buy | $6.8M | -98.59% | NA | 0.0% |
![]() Regeneron Pharmaceuticals, Inc. | Buy | $124.7B | 305.56% | 29.93 | 32.04% |
![]() Novo Nordisk A/s | Buy | $585.3B | 417.73% | 44.01 | 34.84% |
![]() Alnylam Pharmaceuticals, Inc. | Buy | $32.3B | 198.44% | NA | -3.11% |
![]() Vertex Pharmaceuticals Incorporated | Buy | $120.9B | 167.72% | 32.84 | -4.74% |
Insights on Tff Pharmaceuticals Inc
In the last 1 year, Regeneron Pharmaceuticals, Inc. has given 37.1% return, outperforming this stock by 117.9%
In the last 3 years, Novo Nordisk A/s has given 69.2% return, outperforming this stock by 168.4%
Carlson Capital LP
Armistice Capital, LLC
Westside Investment Management, Inc.
DRW Securities, LLC
Geode Capital Management, LLC
Renaissance Technologies Corp
tff pharmaceuticals, inc. is a clinical-stage biopharma company focused on developing and commercializing drug products based on its patented thin film freezing (tff) technology. our patented thin film freezing (tff) platform makes it possible to turn more molecules into inhalable therapies. this novel technology provides high absorption and yield, uniform particle size, gentle process and endless possibilities. tff pharmaceuticals has two lead drug candidates: voriconazole inhalation powder and tac-lac inhalation powder. the company plans to add to this pipeline by collaborating with large pharmaceutical partners. the tff platform is protected by 42 patents issued or pending in the us and internationally.
Organization | Tff Pharmaceuticals Inc |
Employees | 19 |
CEO | Dr. Harlan F. Weisman |
Industry | Health Technology |
A Spac I Acquisition Corp
$1.79
-8.67%
Keyarch Acquisition Corp
$1.79
-8.67%
Connexa Sports Technologies Inc
$1.79
-8.67%
Us Value Etf
$1.79
-8.67%
First Wave Biopharma Inc
$1.79
-8.67%
Global X Msci Next Emerging
$1.79
-8.67%
Fat Projects Acquisition Corp
$1.79
-8.67%
Capital Link Global Fintech
$1.79
-8.67%
Applied Uv Inc
$1.79
-8.67%